Trademark applications and grants for Newlink Genetics. Newlink Genetics has 2 trademark applications. The latest application filed is for "HYPERACUTE"
Patent Application | Date |
---|---|
ENHANCED IMMUNOGENICITY OF TUMOR ASSOCIATED ANTIGENS BY ADDITION OF ALPHAGAL EPITOPES 20120003251 - 13/173692 MAUTINO; Mario R. ;   et al. | 2012-01-05 |
IDO Inhibitors 20110136796 - 12/988391 Mautino; Mario R. ;   et al. | 2011-06-09 |
IDO Inhibitors 20110053941 - 12/744860 Mautino; Mario ;   et al. | 2011-03-03 |
Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes 20090060930 - 11/977203 Mautino; Mario R. ;   et al. | 2009-03-05 |
Enhanced immunogenicity of tumor associated antigens by addition of .alpha.gal epitopes 8,357,777 - 13/173,692 Mautino , et al. January 22, 2 | 2013-01-22 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "HYPERACUTE" 3023736 78529346 |
HYPERACUTE 2004-12-08 |
![]() "SAVI" 78154524 |
SAVI 2002-08-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.